Trial NCT01267240

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-02556
Secondary IDs: 8192 CDR0000689859 N01CM00032 N01CM00038 NCI 8192 NCI-2011-02556 PHL-068 PMH-PHL-068

Last trial update was posted on 2017-04-14

MeSH Interventions

Capecitabine Vorinostat

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Recurrence Squamous Cell Carcinoma of Head and Neck

Other Conditions

Paranasal Sinus Squamous Cell Carcinoma Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Oral Cavity Squamous Cell Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Stage IVA Hypopharyngeal Squamous Cell Carcinoma Stage IVA Laryngeal Squamous Cell Carcinoma Stage IVA Oral Cavity Squamous Cell Carcinoma Stage IVA Oropharyngeal Squamous Cell Carcinoma Stage IVB Hypopharyngeal Squamous Cell Carcinoma Stage IVB Laryngeal Squamous Cell Carcinoma Stage IVB Oral Cavity Squamous Cell Carcinoma Stage IVB Oropharyngeal Squamous Cell Carcinoma Stage IVC Hypopharyngeal Squamous Cell Carcinoma Stage IVC Laryngeal Squamous Cell Carcinoma Stage IVC Oral Cavity Squamous Cell Carcinoma Stage IVC Oropharyngeal Squamous Cell Carcinoma

Stopping Reasons

Study treatment did not show clinical activity.

Limitations And Caveats

Early termination due to lack of activity of study drug.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID